Andrew Taylor to Heart Failure
This is a "connection" page, showing publications Andrew Taylor has written about Heart Failure.
Connection Strength
4.691
-
Taylor AJ, Warren J. Diastolic Function and Fibrosis Burden: Improving Prognostication in Heart?Failure. JACC Cardiovasc Imaging. 2023 06; 16(6):797-799.
Score: 0.707
-
Gutman SJ, Costello BT, Papapostolou S, Iles L, Ja J, Hare JL, Ellims A, Marwick TH, Taylor AJ. Impact of sex, socio-economic status, and remoteness on therapy and survival in heart failure. ESC Heart Fail. 2019 10; 6(5):944-952.
Score: 0.555
-
Ellims AH, Pfluger H, Elsik M, Butler MJ, Hare JL, Taylor AJ. Utility of cardiac magnetic resonance imaging, echocardiography and electrocardiography for the prediction of clinical response and long-term survival following cardiac resynchronisation therapy. Int J Cardiovasc Imaging. 2013 Aug; 29(6):1303-11.
Score: 0.353
-
Iles L, Pfluger H, Lefkovits L, Butler MJ, Kistler PM, Kaye DM, Taylor AJ. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. J Am Coll Cardiol. 2011 Feb 15; 57(7):821-8.
Score: 0.304
-
Taylor AJ, Elsik M, Broughton A, Cherayath J, Leet A, Wong C, Iles L, Butler M, Pfluger H. Combined dyssynchrony and scar imaging with cardiac magnetic resonance imaging predicts clinical response and long-term prognosis following cardiac resynchronization therapy. Europace. 2010 May; 12(5):708-13.
Score: 0.285
-
Iles L, Pfluger H, Phrommintikul A, Cherayath J, Aksit P, Gupta SN, Kaye DM, Taylor AJ. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol. 2008 Nov 04; 52(19):1574-80.
Score: 0.260
-
Marasco SF, McLean J, Kure CE, Rix J, Lake T, Linton A, Farag J, Zhu MZL, Doi A, Bergin PJ, Leet AS, Taylor AJ, Hare JL, Patel HC, Kaye D, McGiffin DC. HeartMate 3 implantation with an emphasis on the biventricular configuration. Artif Organs. 2024 Jun; 48(6):655-664.
Score: 0.188
-
Segan L, Chieng D, Sugumar H, Voskoboinik A, Ling LH, Costello B, Azzopardi S, Nderitu Z, Parameswaran R, Amerena J, McLellan AJ, Lee G, Morton J, Joseph S, Wong M, Taylor A, Kalman JM, Kistler PM, Prabhu S. The impact of age on ablation outcomes in AF-mediated cardiomyopathy. J Cardiovasc Electrophysiol. 2023 10; 34(10):2065-2075.
Score: 0.182
-
Chieng D, Sugumar H, Segan L, Tan C, Vizi D, Nanayakkara S, Al-Kaisey A, Hawson J, Prabhu S, Voskoboinik A, Finch S, Morton JB, Lee G, Mariani J, La Gerche A, Taylor AJ, Howden E, Kistler PM, Kalman JM, Kaye DM, Ling LH. Atrial Fibrillation Ablation for Heart?Failure With Preserved Ejection?Fraction: A Randomized Controlled Trial. JACC Heart Fail. 2023 06; 11(6):646-658.
Score: 0.175
-
Dagan M, Lankaputhra M, Yeung T, Tee SL, Bader I, Easton K, Linton A, McLean C, Taylor A, Bergin P, Kaye DM, Leet A, Hare JL, Patel HC. Incidence and Predictors of Eosinophilic Myocardial Hypersensitivity in Patients Receiving Home Dobutamine. J Cardiovasc Pharmacol. 2022 10 01; 80(4):623-628.
Score: 0.170
-
Powell C, Ismail H, Davis M, Taylor A, Breen L, Fylan B, Alderson SL, Gale CP, Kellar I, Silcock J, Alldred DP. Experiences of patients with heart failure with?medicines at transition intervention: Findings from the process evaluation of the Improving the Safety and Continuity of Medicines management at Transitions of care?(ISCOMAT) programme. Health Expect. 2022 10; 25(5):2503-2514.
Score: 0.168
-
Moreau LA, Holloway I, Fylan B, Hartley S, Cundill B, Fergusson A, Alderson S, Alldred DP, Bojke C, Breen L, Ismail H, Gardner P, Mason E, Powell C, Silcock J, Taylor A, Farrin A, Gale C. Using routine healthcare data to evaluate the impact of the Medicines at Transitions Intervention (MaTI) on clinical outcomes of patients hospitalised with heart failure: protocol for the Improving the Safety and Continuity Of Medicines management at Transitions of care (ISCOMAT) cluster randomised controlled trial with embedded process evaluation, health economics evaluation and internal pilot. BMJ Open. 2022 04 29; 12(4):e054274.
Score: 0.165
-
Yeung T, Dagan M, Lankaputhra M, Cieslik L, Warner V, Leet A, Hare JL, Bergin P, Taylor AJ, Kaye DM, Patel HC. Levosimendan and Continuous Outpatient Support With Inotropes in Patients With Advanced Heart Failure: A Single-Centre Descriptive Study. J Cardiovasc Pharmacol. 2022 04 01; 79(4):583-592.
Score: 0.165
-
Batchelor RJ, Wong N, Liu DH, Chua C, William J, Tee SL, Sata Y, Bergin P, Hare J, Leet A, Taylor AJ, Patel HC, Burrell A, McGiffin D, Kaye DM. Vasoplegia Following Orthotopic Heart Transplantation: Prevalence, Predictors and Clinical Outcomes. J Card Fail. 2022 04; 28(4):617-626.
Score: 0.162
-
Sugumar H, Nanayakkara S, Vizi D, Wright L, Chieng D, Leet A, Mariani JA, Voskoboinik A, Prabhu S, Taylor AJ, Kalman JM, Kistler PM, Kaye DM, Ling LH. A prospective STudy using invAsive haemodynamic measurements foLLowing catheter ablation for AF and early HFpEF: STALL AF-HFpEF. Eur J Heart Fail. 2021 05; 23(5):785-796.
Score: 0.153
-
McGiffin D, Kure C, McLean J, Marasco S, Bergin P, Hare JL, Leet A, Patel H, Zimmet A, Rix J, Taylor A, Kaye D. The results of a single-center experience with HeartMate 3 in a biventricular configuration. J Heart Lung Transplant. 2021 03; 40(3):193-200.
Score: 0.151
-
Nguyen MN, Su Y, Vizi D, Fang L, Ellims AH, Zhao WB, Kiriazis H, Gao XM, Sadoshima J, Taylor AJ, McMullen JR, Dart AM, Kaye DM, Du XJ. Mechanisms responsible for increased circulating levels of galectin-3 in cardiomyopathy and heart failure. Sci Rep. 2018 05 29; 8(1):8213.
Score: 0.126
-
Prabhu S, Voskoboinik A, McLellan AJA, Peck KY, Pathik B, Nalliah CJ, Wong GR, Azzopardi SM, Lee G, Mariani J, Ling LH, Taylor AJ, Kalman JM, Kistler PM. Biatrial Electrical and Structural Atrial?Changes in Heart Failure: Electroanatomic Mapping in Persistent Atrial Fibrillation in?Humans. JACC Clin Electrophysiol. 2018 01; 4(1):87-96.
Score: 0.121
-
Stokes MB, Taylor AJ, McLean CA, D'Arcy CE, Mariani JA. Severe left ventricular hypertrophy and marked cardiac fibrosis in Danon disease. Int J Cardiol. 2016 Oct 15; 221:14-6.
Score: 0.110
-
Voigt J, Sasha John M, Taylor A, Krucoff M, Reynolds MR, Michael Gibson C. A reevaluation of the costs of heart failure and its implications for allocation of health resources in the United States. Clin Cardiol. 2014 May; 37(5):312-21.
Score: 0.095
-
van der Merwe J, Leong JY, Kaye D, Opat S, Bergin PJ, Taylor AJ, Rosenfeldt F. Antioxidant therapy for severe cardiac failure induced by iron overload secondary to dyserythropoietic anaemia. Heart Lung Circ. 2007 Oct; 16(5):394-7.
Score: 0.058
-
Ling LH, Taylor AJ, Ellims AH, Iles LM, McLellan AJ, Lee G, Kumar S, Lee G, Teh A, Medi C, Kaye DM, Kalman JM, Kistler PM. Sinus rhythm restores ventricular function in patients with cardiomyopathy and no late gadolinium enhancement on cardiac magnetic resonance imaging who undergo catheter ablation for atrial fibrillation. Heart Rhythm. 2013 Sep; 10(9):1334-9.
Score: 0.022
-
Gould PA, Kong G, Kalff V, Duffy SJ, Taylor AJ, Kelly MJ, Kaye DM. Improvement in cardiac adrenergic function post biventricular pacing for heart failure. Europace. 2007 Sep; 9(9):751-6.
Score: 0.015